Search Results for: DNR
D.R. Horton reported disappointing fourth-quarter and full-year earnings before markets opened Tuesday morning.
Published:
Last Updated:
Swiss drug company Roche is trying to steal the part of biotech company Genentech (DNA) that it does not already own. Roche has offered to buy the 45% of DNA that belongs to public shareholders for...
Published:
Last Updated:
Alpha Natural Resources Inc. (NYSE: ANR) filed its intent to raise an aggregate of up to $400 million through offering $250 million for their convertible senior notes due 2015 and a concurrent common...
Published:
Last Updated:
Genentech (NYSE: DNA) just announced its earnings were $0.69 EPS on $2.96 billion for the last quarter, and First Call had estimates pegged at $0.67 EPS on revenues of $2.97 Billion. The...
Published:
Last Updated:
Turner Investments Inc. has filed to come public via an IPO. For filing purposes it listed $150 million as the amount up to which it will securities, although this is nominal and usually...
Published:
Offshore driller Cal Dive International Inc. (NYSE:DVR) reported third quarter earnings after markets closed yesterday. The company announced EPS of $0.44 on revenue of $278.7 million. Analysts had...
Published:
Last Updated:
By Chad Brand of Peridot CapitalistWhen I wrote about the Merck (MRK) deal to acquire Sirna Therapeutics (RNAI) on 10/31 and predicted more biotech deals were coming, I didn’t realize it would...
Published:
Applied DNA Sciences shares made an incredible gain on Thursday after the company announced it had received an update from the FDA concerning its COVID-19 assay kit.
Published:
Independent oil & gas company Harvest Natural Resources Inc. (NYSE: HNR) today announced the sale of its Venezuelan assets to Pertamina, the national oil company of Indonesia, for $725 million in...
Published:
The three major US equities indexes opened sharply lower this morning as there has been no news to counteract the weak economic projections that came out yesterday. The projected -0.3% contraction in...
Published:
We are seeing unusual trading activity so far this morning in shares of Dendreon Corp. (NASDAQ: DNDN), Genentech, Inc. (NYSE: DNA), Genzyme Corp. (NASDAQ: GENZ), and PDL BioPharma, Inc. (Nasdaq:...
Published:
Last Updated:
Two weeks ago, Cliffs Natural Resources (NYSE:CLF) pushed out its shareholder vote on a merger with Alpha Natural Resources (NYSE:ANR) to mid-December. Alpha promptly filed suit, seeking to force...
Published:
Last Updated:
Shares of ImaRx Therapeutics (IMRX) are off 15% to $1.18. The company’s news about it Transcranial Ultrasound in Clinical SONolysis clinical trial in patients with acute ischemic stroke...
Published:
Last Updated:
Natural gas producer Vanguard Natural Resources LLC (NYSE: VNR) announced this morning that it has agreed to purchase natural gas and liquids assets from privately held Antero Resources for about...
Published:
This morning shares of Genentech (DNA-NYSE) are trading up 1.3% at just under $76.00 after a Deutsche Bank upgrade on the stock. Shares closed at $74.90 yesterday and even traded as low as...
Published: